Cardiac & Cardiothoracic

FloraSeal® SurgiSeal® PlasmaBlade™ Aquamantys™ RadiaLux™ Negative Pressure Wound Therapy
  • When compared with non-infectious cardiac device complications, pacemaker infections result in an 8.4x to 11.6x increase in mortality rates along with a mean hospitalisation cost ranging from $31,149 to $55,003.[1]
  • Adding microbial skin sealant results in less contamination of the incision by endogenous skin microbes by the end of the surgical procedure than standard skin prep techniques. There is a subsequent reduction in the risk of Surgical Site Infection (SSI), which is particularly pronounced in obese patients.[2]
FloraSeal®
  • FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[3]

1. Fakhro, A., Jalalabadi, F., Brown, R. H., & Izaddoost, S. A. (2016). Treatment of Infected Cardiac Implantable Electronic Devices. Seminars in plastic surgery, 30(2), 60–65.

2. von Eckardstein, A. S., Lim, C. H., Dohmen, P. M., Pêgo-Fernandes, P. M., Cooper, W. A., Oslund, S. G., & Kelley, E. L. (2011). A randomized trial of a skin sealant to reduce the risk of incision contamination in cardiac surgery. The Annals of thoracic surgery, 92(2), 632–637.

3. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.

FloraSeal®

1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

Cardiac:

  • Reduced risk of thermal damage to transvenous leads[4]
  • Precise dissection with less risk of thermal and mechanical lead damage[4,5,6]
  • Reduced ventricular oversensing or other CIED interactions[4,5]
  • Shown to decrease procedure time by up to 40%, decrease lead damage events, and avoid prolonged hospital stays, resulting in an average cost savings of $155 per case[7]
PlasmaBlade™

PROCEDURES

  • Generator changeouts
  • Generator replacements
  • Generator upgrades
  • Capsulectomy

Cardiothoracic:

  • In thoracic artery harvesting, PlasmaBlade™ demonstrated significantly less endothelial damage than traditional electrosurgery (83% vs 60%)[8]
  • PlasmaBlade™ samples demonstrated a tendency to better wall integrity than traditional electrosurgery (72% vs. 54%)[8]

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.
5. Weisberg IL, Desai S, Vose JG, Knight BP. Abstract presented from the podium at Heart Rhythm Society 2010 and Cardiostim 2010.

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.
5. Weisberg IL, Desai S, Vose JG, Knight BP. Abstract presented from the podium at Heart Rhythm Society 2010 and Cardiostim 2010.
6. Kypta A, Blessberger H, Saleh K, Hönig S, Kammler J, Steinwender C. An electrical plasma surgery tool for device replacement--retrospective evaluation of complications and economic evaluation of costs and resource use. PACE 2014; 00:1–7.

7. Vose JG, McAdara-Berkowitz J. Reducing scalpel injuries in the operating room. AORN J. 2009;90(6):867-872.

8. Zientara A, Komminoth P, Seifert B, Odavic D, Dzemali O, Häussler A, Genoni M. Skeletonized internal thoracic artery harvesting: a low thermal damage electrosurgical device provides improved endothelial layer and tendency to better integrity of the vessel wall compared to conventional electrosurgery. J Cardiothorac Surg. 2018;13:105.

Cardiac:

  • Significantly reduced the incidence of haematoma[9]
  • Reduced the need for other haemostatic agents[10]
  • Reduced surgical time[11]
  • Reduced intraoperative blood loss[12]
Aquamantys™

PROCEDURES

  • Generator changeouts
  • Generator replacements
  • Generator upgrades
  • Capsulectomy

Cardiothoracic:

  • Use of the Aquamantys™ during lung resection resulted in reduced transfusion rates compared to traditional electrosurgery (1.8% vs. 14.7%)[13]
  • Significantly less drainage at day 1,2, and 3[13]
  • An average 2.1-day reduction in chest tube permanence time was found when using the Aquamantys™[13]
  • Use of the Aquamantys™ during lung resection resulted in an average of 21.9-minute reduction in operating time compared to traditional electrosurgery[13]
  • Use of the Aquamantys™ during lung resection resulted in an average of 2.2-day reduction in hospital stay compared to traditional electrosurgery[13]

PROCEDURES

  • Decortication
  • Lung resection
  • Mediastinal lymph node dissection
  • Chest wall resection
  • Video Assisted Thoracoscopic Surgery (VATS)

9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

10. Geller DA, Tsung A, Maheshwari V, et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB. 2005;7:208-213.

11. Snyder BD, Hedequist D, Shannon E. Bipolar sealing technology to control bleeding in pediatric spine surgery: a retrospective study. Poster presentation at Pediatric OrthopaedicSociety of North America Annual Meeting. 2007;Hollywood, FL.

12. Gordon ZL, Son-Hing JP, Poe-Kochert C, Thompson GH. Bipolar sealer device reduces blood loss and transfusion requirements in posterior spinal fusionfor adolescent idiopathicscoliosis. J Pediatr Orthop. 2013;33(7):700-706.

13. Ibrahim M, Menna C, Maurizi G, et al. Impact of Transcollation technology in thoracic surgery: a retrospective study. Eur J Cardiothorac Surg. 2016;46(2):623–6.

  • The RadiaLux™ lighted retractor is a single-use retractor designed to provide surgeons with the ability to manipulate soft tissue through a combination of blades when assembled onto a retractor handle.
  • The retractor provides illumination to the surgical field independent of an external light source or fibre optic cables.
  • The lighted retractor is indicated for enhancing visibility to a surgical field through retraction of soft tissue and illumination of the surgical cavity.
RadiaLux™

According to a recent review, application of a single-use negative pressure wound therapy system reduced the rate of SSI by 58% compared to standard of care. Additionally, patients had less hospital LOS compared to standard of care.[1]

RadiaLux™

The Genadyne NPWT portfolio is completely comprehensive, from Ultraportable Single-Use and Reusable Pumps to High Demand and Instil Pumps. The Dressing Portfolio is compatible across all NPWT Pumps, allowing for an all-inclusive ecosystem for a hospital institution. From Absorbent Dressings that can be used with or without NPWT, ready to use Foam Dressings, and all the way to large Foam Kits, Abdominal Kits and PVA Kits.

Closed incision management negative pressure has been proven to:

  • Protect the incision from external contamination
  • Hold closed incision wound edges together
  • Help reduce tensile forces across the incision
  • Help reduce oedema
  • Reduce seroma and haematoma fluid collection
  • Suitable for dehisced wounds, trauma wounds, partial thickness burns, flaps and grafts

Green Foam

More than just a colour…

The visual impact of the Genadyne Green Foam is undeniable. Green was chosen to allow clinicians to better differentiate between viable and nonviable tissue in the wound bed. The colour contrast increases differentiation with the wound bed.

RadiaLux™

Competitor

RadiaLux™

Patented Genadyne Green Foam

  • Genadyne Green Foam is a fully reticulated polyurethane foam made with polyether resin to allow better hydrolytic stability. The design increases performance under pressure and in moist environments.
  • The Dodecahedron cell structure gives a three-dimensional skeletal strand to the cells providing enhanced filtering qualities and increasing the removal of exudate and infectious materials. This cell structure also increases tensile strength to prevent fraying. Fraying is significantly reduced, preventing stray pieces from being left in the wound bed.
  • The combination of cell structure and composition gives the foam a non-adherent property, allowing for easier removal during dressing changes, thereby reducing pain and discomfort.
  • The foam creates direct contact with the wound bed, allowing for even distribution of pressure. This assists in reducing oedema and promotes tissue perfusion and granulation.

Properties

Benefits

Fully reticulated polyurethane foam

Increased hydrolytic stability

Polyether resin

Increased tensile strength

Pore Size

Boosts performance under pressure

Dodecahedron cell structure / 3 dimensional skeletal strands

Enhanced filtering qualities
Increased tensile strength
Reduced risk of fraying
Non-adherent properties
Reduced discomfort during dressing change

Variable Pressure

The advanced variable pressure capabilities of all of the Genadyne Negative Pressure Pumps, allow different negative pressures to be used without the downsides of painful intermittent therapy.

By maintaining negative pressure throughout the cycle, variable negative pressure wound therapy avoids losing an airtight seal and displacement of the dressing. This gradual “wave” is gentler to the patient increasing blood flow to the peri-wound and preventing ischemia. The changes in pressure are imperceptible to the patient, increasing patient comfort and compliance.

The literature suggests that the use of Variable Pressure is beneficial. It results in decreased blood flow that is known to stimulate angiogenesis and granulation tissue formation and to increase blood flow that is known to facilitate oxygenation and nutrient supply and removal of waste products. [2]

Cycling the negative pressure level may be beneficial especially when treating poorly vascularized tissue with a risk for development of ischemia, as pressure is released repeatedly.[2]

Image

Revolution Surgical Pty Ltd
4/22 Rowood Road, Prospect NSW 2148
ABN: 63 165 643 434

© 2018-2024 Revolution Surgical

Website by: WebInjection